about
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cellsImpact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular PressureSafety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens.Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma.Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.Glucocorticoids and rheumatoid arthritis: back to the future?Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.Higher incidence of steroid-induced ocular hypertension in keratoconusInducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.Side effects of short-term oral corticosteroids.Steroid induced diabetes mellitus in patients receiving prednisolone for haematological disorders.Pharmacotherapy of uveitis.Steroid-induced iatrogenic glaucoma.Management of seasonal allergic conjunctivitis: guide to therapy.Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review.Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?The Pathogenesis of Raised Intraocular Pressure in Uveitis.Long-term side effects of glucocorticoids.Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering SurgeriesA single gene connects stiffness in glaucoma and the vascular system.Glaucoma and corneal transplant procedures.The best of the best: a review of select glaucoma case reports published in 2015.Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.Ophthalmic Manifestations in Chronic Inflammatory Rheumatic Diseases at a Referral Hospital of Yaounde, Cameroon.Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis
P2860
Q24644700-166A311D-AC16-414C-8112-FC7C9C3E4B76Q26764956-D3C1B4C9-7EAF-4496-A1E3-8148494990F9Q31000488-5EC50F48-CF22-44A3-A69A-7599ACACA43AQ33538277-D9B1A92F-C950-4B80-8597-BDA0E6EBA16BQ33938206-DBEC2266-819F-4708-B247-6ECB5D9FC328Q33994706-CE1EB3A4-BFAA-4CCF-95F1-6D8AC5BA6B4FQ34080132-E9BEEDF7-0451-4B0B-AE2E-BD4C08B1326DQ34509564-89117980-A50F-420D-8C09-8B486CF3329FQ34575021-AF59D045-C12C-4C66-A587-A367755EDA3BQ34972556-CD2DBAAC-1D44-4422-8E1D-C010FDFDB857Q35752563-FC2E38CB-2029-40CD-A3BD-F7E9FC7F354DQ35933577-151B5A88-7330-4541-9A5C-49F20C909439Q36880023-0BFFF8F6-F72C-4F6B-8372-3B2E48980CB2Q37059858-37212547-A517-41FE-B71E-5D157DB6D311Q37112046-0299FE4A-D192-45AE-96FE-2B343DDF77F2Q37298935-C38C601B-C058-45D4-821F-0D03831AD7E1Q37724245-2AF3D372-9026-4590-97DD-E9CE0EEE3851Q37901293-633EB52F-5FC9-4C8B-942D-5CD0C5DB1DB6Q37954005-2512BB13-5E9F-4D09-808E-91730A8EA4BBQ38019465-D0E3187C-BAB1-4889-B977-D26B033914F7Q38081194-75A11973-6218-4A98-AEA1-33A3DC666715Q38212219-00A0371F-F8CA-447D-BDBC-9FA87DCC09E4Q38241140-8941A2A3-93F1-4513-92B7-6133B7137D8BQ38479685-3CA282E7-4070-407A-B65F-B4F15131065BQ38703908-E52BA580-4CBF-4A2C-BCEE-801B40B9ED71Q38788689-00F99837-EF03-43B0-8012-DB68A3A9739EQ38946174-11501B98-8D6F-4E91-9B03-BC3BCEA6F200Q40796983-5F8829EC-A64D-4DC2-8E02-E3F9C29D9433Q41152250-543F8126-29CB-4BD9-B930-2DAB0CACCAEBQ42676528-899DF7F6-CD49-4754-AB5F-FE7E03276E33Q46908156-EFEC0514-EAF6-4999-BD64-B71FF5ABDD8DQ57266992-96D545B7-19C6-4FF5-BB39-A5F5901A5D5B
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Corticosteroids and glaucoma risk.
@ast
Corticosteroids and glaucoma risk.
@en
type
label
Corticosteroids and glaucoma risk.
@ast
Corticosteroids and glaucoma risk.
@en
prefLabel
Corticosteroids and glaucoma risk.
@ast
Corticosteroids and glaucoma risk.
@en
P2093
P1433
P1476
Corticosteroids and glaucoma risk.
@en
P2093
Parapuram SK
Tripathi BJ
Tripathi RC
P304
P356
10.2165/00002512-199915060-00004
P577
1999-12-01T00:00:00Z
P6179
1012375996